Apoptotic signaling by c-MYC

被引:407
作者
Hoffman, B. [1 ]
Liebermann, D. A. [1 ]
机构
[1] Temple Univ, Sch Med, Dept Biochem, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA
关键词
c-MYC; apoptosis; Bcl-2; family; mitochondria; death receptors; cancer;
D O I
10.1038/onc.2008.312
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
c-MYC has a pivotal function in growth control, differentiation and apoptosis, and its abnormal expression is associated with many tumors. Overexpression of c-MYC sensitizes cells to apoptosis by a variety of stimuli. The decision of a cell to undergo apoptosis and how this apoptotic response is regulated by c-MYC depends on the specific cell type and the physiological status of the cell. Multiple cooperating molecular pathways of cell survival and apoptosis determine whether a cell lives or dies, and understanding how c-MYC interfaces with these pathways to influence the survival of cells is important to understand normal and abnormal development, tumor initiation and progression, and response of tumors to different treatment regimens. This article will provide an overview of the function of the tumor suppressor gene product p53 in the c-MYC-mediated apoptotic response and how c-MYC amplifies the intrinsic mitochondrial pathway and triggers and/or amplifies the death receptor pathways. Finally, a model for how deregulated c-MYC prematurely triggers the normal apoptotic response associated with terminal myeloid differentiation while also blocking the differentiation program is presented.
引用
收藏
页码:6462 / 6472
页数:11
相关论文
共 91 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]   Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector [J].
Adams, JM ;
Harris, AW ;
Strasser, A ;
Ogilvy, S ;
Cory, S .
ONCOGENE, 1999, 18 (38) :5268-5277
[3]   Cell biology - Double knockout blow for caspases [J].
Adrain, C ;
Martin, SJ .
SCIENCE, 2006, 311 (5762) :785-786
[4]   Deregulated c-Myc prematurely recruits both Type I and IICD95/Fas apoptotic pathways associated with terminal myeloid differentiation [J].
Amanullah, A ;
Liebermann, DA ;
Hoffman, B .
ONCOGENE, 2002, 21 (10) :1600-1610
[5]   p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation [J].
Amanullah, A ;
Liebermann, DA ;
Hoffman, B .
ONCOGENE, 2000, 19 (26) :2967-2977
[6]   MYC-MAX-MAD - A TRANSCRIPTION FACTOR NETWORK CONTROLLING CELL-CYCLE PROGRESSION, DIFFERENTIATION AND DEATH [J].
AMATI, B ;
LAND, H .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) :102-108
[7]   p14ARF directly interacts with Myc through the Myc BoxII domain [J].
Amente, Stefano ;
Gargano, Barbara ;
Varrone, Francesca ;
Ruggiero, Luca ;
Dominguez-Sola, David ;
Lania, Luigi ;
Majello, Barbara .
CANCER BIOLOGY & THERAPY, 2006, 5 (03) :287-291
[8]   Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents [J].
Amundson, SA ;
Zhan, Q ;
Penn, LZ ;
Fornace, AJ .
ONCOGENE, 1998, 17 (17) :2149-2154
[9]   Rax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis [J].
Annis, MG ;
Dlugosz, PJ ;
Cruz-Aguado, JA ;
Penn, LZ ;
Leber, B ;
Andrews, DW .
EMBO JOURNAL, 2005, 24 (12) :2096-2103
[10]  
ASKEW DS, 1991, ONCOGENE, V6, P1915